Persistence with mirabegron therapy for overactive bladder: A real life experience
Sign Up to like & getrecommendations! Published in 2017 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.22943
Abstract: To evaluate persistence rates of patients receiving mirabegron therapy for overactive bladder (OAB) within our institution over a 6 month period, identify determinants of early discontinuation of therapy, and assess overall patient satisfaction with treatment. read more here.
Keywords: therapy overactive; overactive bladder; therapy; persistence ... See more keywords